• Study Comparing Lidocaine Gel and Tetracaine/Oxybuprocaine Eye Drops for Glaucoma Patients Undergoing Outpatient Needling Procedures

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Spain
  • Study on the Effectiveness of GP2 and Sargramostim for HER2 Positive Breast Cancer Patients with Residual Disease or High-Risk After Standard Therapy

    Recruiting

    3 1
    Austria Belgium France Germany Ireland Italy +4
  • Study on Hexaminolevulinate for Patients with Non-Muscle Invasive Bladder Cancer to Reduce Need for Second Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Italy
  • Study on Lomustine with or without Additional Brain Radiation for Patients with Recurrent Glioblastoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Belgium Czechia Denmark France Germany +4
  • Study on Long-Term Safety of Luspatercept for Patients with Myelodysplastic Syndrome, Beta-Thalassemia, or Myelofibrosis Who Previously Participated in Luspatercept Trials

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Bulgaria France Germany Greece Italy The Netherlands +2
  • Study Comparing Quinidine and Verapamil for Patients with Short-Coupled Idiopathic Ventricular Fibrillation

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Study on Fasudil Hydrochloride for Memory Loss Prevention in Early Alzheimer’s Disease Patients

    Recruiting

    2 1
    Investigated Drugs:
    Norway
  • Study Comparing Ciprofloxacin, Colistimethate Sodium, and Ceftazidime for Treating Early Airway Infection in Adults with Bronchiectasis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    France
  • Study on the Effectiveness and Safety of KarXT for Treating Psychosis in Patients with Alzheimer’s Disease

    Recruiting

    3 1
    Belgium Greece Hungary Poland
  • Study on the Effects of Ketamine on Therapy Intensity and Brain Pressure in Patients with Traumatic Brain Injury

    Recruiting

    3 1 1
    Investigated Drugs:
    Belgium

powered by